KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients

KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients

Abstract Background Mutated KRAS may indicate an invasive nature and predict prognosis in locally advanced rectal cancer (LARC). We aimed to establish a radiomic model using pretreatment T2W MRIs to predict KRAS status and explore the association between the KRAS status or model predictions and lung...

Bibliografski detalji
Glavni autori:	Yirong Xiang, Shuai Li, Maxiaowei Song, Hongzhi Wang, Ke Hu, Fengwei Wang, Zhi Wang, Zhiyong Niu, Jin Liu, Yong Cai, Yongheng Li, Xianggao Zhu, Jianhao Geng, Yangzi Zhang, Huajing Teng, Weihu Wang
Format:	Članak
Jezik:	English
Izdano:	BMC 2023-12-01
Serija:	BMC Medical Imaging
Teme:	Locally advanced rectal cancer KRAS Radiomics Lung Metastasis
Online pristup:	https://doi.org/10.1186/s12880-023-01173-5

Slični predmeti

MRI T2WI-based radiomics combined with KRAS gene mutation constructed models for predicting liver metastasis in rectal cancer
od: Jiaqi Ma, i dr.
Izdano: (2024-10-01)

Outcomes and failure patterns after chemoradiotherapy for locally advanced rectal cancer with positive lateral pelvic lymph nodes: a propensity score-matched analysis
od: Shuai Li, i dr.
Izdano: (2024-10-01)

Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
od: Shengbin Zheng, i dr.
Izdano: (2025-01-01)

A Disentangled Representation-Based Multimodal Fusion Framework Integrating Pathomics and Radiomics for KRAS Mutation Detection in Colorectal Cancer
od: Zhilong Lv, i dr.
Izdano: (2024-09-01)

Using tumor habitat-derived radiomic analysis during pretreatment 18F-FDG PET for predicting KRAS/NRAS/BRAF mutations in colorectal cancer
od: Hongyue Zhao, i dr.
Izdano: (2024-02-01)

Different radiomics annotation methods comparison in rectal cancer characterisation and prognosis prediction: a two-centre study
od: Ying Zhu, i dr.
Izdano: (2024-08-01)

Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer
od: Yue Teng, i dr.
Izdano: (2024-01-01)

Radiomics in rectal cancer: current status of use and advances in research
od: Wei-Qin Huang, i dr.
Izdano: (2025-01-01)

Multi‐Institutional MR‐Derived Radiomics to Predict Post‐Exenteration Disease Recurrence in Patients With T4 Rectal Cancer
od: Niall J. O'Sullivan, i dr.
Izdano: (2025-02-01)

Comparison of conventional MRI analysis versus MRI-based radiomics to predict the circumferential margin resection involvement of rectal cancer
od: Hong Liang, i dr.
Izdano: (2024-06-01)

Radiomic score for lung nodules as a prognostic biomarker in locally advanced rectal cancer patients: A bi‐institutional study
od: Zhiyuan Zhang, i dr.
Izdano: (2024-06-01)

A Machine Learning Model Based on MRI Radiomics to Predict Response to Chemoradiation Among Patients with Rectal Cancer
od: Filippo Crimì, i dr.
Izdano: (2024-11-01)

Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy
od: Wang Yang, i dr.
Izdano: (2024-01-01)

Comparative performance of multiple ensemble learning models for preoperative prediction of tumor deposits in rectal cancer based on MR imaging
od: Jiayi Wang, i dr.
Izdano: (2025-02-01)

Radiation hematologic toxicity prediction in rectal cancer: a comparative radiomics-based study on CT image and dose map
od: Yingpeng Liu, i dr.
Izdano: (2025-03-01)

Prediction by a multiparametric magnetic resonance imaging-based radiomics signature model of disease-free survival in patients with rectal cancer treated by surgery
od: Jiwei Mao, i dr.
Izdano: (2024-02-01)

Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach
od: Sara Dalmonte, i dr.
Izdano: (2025-01-01)

Preoperative prediction of rectal Cancer staging combining MRI deep transfer learning, radiomics features, and clinical factors: accurate differentiation from stage T2 to T3
od: Lifang Fan, i dr.
Izdano: (2024-08-01)

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
od: Szu-Aun Long, i dr.
Izdano: (2024-05-01)

A combinatorial MRI sequence-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer
od: Xiaowei Xing, i dr.
Izdano: (2024-05-01)

Investigating the Feasibility of Predicting KRAS Status, Tumor Staging, and Extramural Venous Invasion in Colorectal Cancer Using Inter-Platform Magnetic Resonance Imaging Radiomic Features
od: Mohammed S. Alshuhri, i dr.
Izdano: (2023-11-01)

Targeting KRAS: from metabolic regulation to cancer treatment
od: Yanyan Shi, i dr.
Izdano: (2025-01-01)

Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches
od: Gizem Kaval, i dr.
Izdano: (2024-04-01)

Machine Learning-Based Radiomics Analysis for Identifying KRAS Mutations in Non-Small-Cell Lung Cancer from CT Images: Challenges, Insights and Implications
od: Mirjam Schöneck, i dr.
Izdano: (2025-01-01)

Ponorni kontaktni kras Zrenjskega ravnika, Istra, Hrvaška
od: Uroš Stepišnik
Izdano: (2022-12-01)

Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features
od: Siyuan Qin, i dr.
Izdano: (2024-09-01)

Prediction of lateral lymph node metastasis in rectal cancer patients based on MRI using clinical, deep transfer learning, radiomic, and fusion models
od: Yi Sun, i dr.
Izdano: (2024-07-01)

The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis
od: Rui Zhao, i dr.
Izdano: (2024-11-01)

Texture Analysis and Prediction of Response to Neoadjuvant Treatment in Patients with Locally Advanced Rectal Cancer
od: Ilaria Mariani, i dr.
Izdano: (2024-10-01)

The value of radiomics based on T2WI and DWI of MRI in preoperative prediction of extramural vascular invasion in rectal cancer
od: DING Jingfeng, AO Weiqun, ZHU Zhen, SUN Jing, XU Lianggen, ZHENG Shibao, YU Jingjing, HU Jinwen
Izdano: (2024-02-01)

MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis
od: Zhongfan Liao, i dr.
Izdano: (2025-03-01)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
od: TingDan Hu, i dr.
Izdano: (2024-07-01)

Predicting pathological complete response following neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer using merged model integrating MRI-based radiomics and deep learning data
od: Haidi Lu, i dr.
Izdano: (2024-10-01)

Kontaktni kras v Kočevskem Rogu in Kočevski Mali gori
od: Petra Gostinčar
Izdano: (2011-12-01)

A subset of flavaglines inhibits KRAS nanoclustering and activation
od: Yurugi, Hajime, i dr.
Izdano: (2021)

Rictor/mTORC2 signaling promotes proliferation and tumorigenicity of Kras mutant cancer cells
od: LAI Huiling, CHEN Shuqin
Izdano: (2025-01-01)

Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer
od: Han Wu, i dr.
Izdano: (2025-02-01)

Clinical Significance of the KRAS Mutation
od: Sead Beganovic
Izdano: (2010-10-01)

Editorial: KRAS in stage IV non-small cell lung cancer
od: Anneloes L. Noordhof, i dr.
Izdano: (2025-03-01)

Complete remission in a pretreated, microsatellite-stable, KRAS-mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy: a case report and literature review
od: Lijuan He, i dr.
Izdano: (2024-03-01)